Found 8 matching trials
A Study of Ponesimod in Healthy Adult Participants Receiving Propranolol at Steady State PHASE1 The primary purpose of this study is to evaluate the effect of the up-titra...
Show More Location
SGS Clinical Pharmacology Unit (located in ZNA Stuivenberg)
Learn More & Join Trial
ACT-128800 in Psoriasis PHASE2 This study will assess the efficacy, safety, and tolerability of ACT-128800...
Show More Location
Landeskrankenhaus - Universitätsklilnikum Graz, Allgemeine Dermatologie
Learn More & Join Trial
Study to Evaluate the Efficacy and Safety of Ponesimod (VSP-128) in Patients With Moderately to Severely Active Ulcerative Colitis PHASE3 A multicenter, randomized, double-blind, placebo-controlled study to evalua...
Show More Location
Vanda Investigational Site
Learn More & Join Trial
Clinical Study to Compare the Efficacy and Safety of Ponesimod to Placebo in Subjects With Active Relapsing Multiple Sclerosis Who Are Treated With Dimethyl Fumarate (Tecfidera®) PHASE3 This clinical study compares the efficacy, safety, and tolerability of ther...
Show More Location
UAB Dpt of Neurology
Learn More & Join Trial
ACT-128800 in Patients With Moderate to Severe Chronic Plaque Psoriasis PHASE2 This study will assess the efficacy, safety and tolerability of two doses o...
Show More Location
Clinical Investigative Site 1006
Learn More & Join Trial
Study of the Electrocardiographic Effects of Ponesimod in Healthy Male and Female Subjects PHASE1 The aim of this study is to demonstrate that therapeutic and supratherapeut...
Show More Location
Covance Clinical Research Unit (CRU)
Learn More & Join Trial
Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ACT-128800 in Healthy Subjects PHASE1 This was a single-center, randomized, double-blind, placebo-controlled, up-...
Show More Location
Quintiles Drug Research Unit at Guy's Hospital
Learn More & Join Trial
Clinical Study to Evaluate the Efficacy, Safety, and Tolerability of ACT-128800 in Patients With Relapsing-remitting Multiple Sclerosis PHASE2 This study will assess the efficacy, safety, and tolerability of ACT-128800...
Show More Location
Clinical Investigative Site 3132
Learn More & Join Trial